Automation Workflow for Medical Device Prototype IP Assessment

Manual review of CAD models, test reports, and requirements to identify patentable features can stall product timelines. This workflow automates feature extraction and novelty scoring, compressing the initial assessment from months to weeks. The time saved accelerates strategic decisions on filing scope and international protection, allowing IP strategy to keep pace with agile development sprints.

Relying on inventor recall and sporadic reviews leads to valuable IP being overlooked or becoming prior art through internal publications. An automated, continuous scan of engineering systems (e.g., SolidWorks, Altium, Jira) and test data ensures comprehensive capture. This systematic approach protects R&D investment by surfacing latent inventions and preventing self-defeating disclosures.

Drafting patent applications from scratch is expensive. By auto-generating structured invention disclosures with extracted features, diagrams, and preliminary claims, this workflow provides patent counsel with a 70-80% complete first draft. This reduces attorney hours spent on information gathering and basic drafting, directly lowering outside legal spend and improving in-house paralegal leverage.

Medical device development is governed by Quality Management Systems (QMS) like ISO 13485 and regulatory submissions. This workflow doesn't operate in a silo; it tags IP artifacts to specific design controls (DHF) and regulatory filing sections. This creates traceability from patent claims to verified product requirements, strengthening regulatory submissions and providing a defensible audit trail for both IP and compliance.

Instead of annual portfolio reviews, this workflow provides a live dashboard mapping patentable features to product roadmaps and competitor landscapes. It enables gap analysis and white-space identification based on real R&D output. Leadership can make strategic filing and maintenance decisions using current data, optimizing portfolio spend and aligning IP directly with commercial objectives.

As R&D output grows, manual IP processes require proportional increases in legal and administrative staff. This automated workflow acts as a force multiplier, allowing the existing IP team to manage a 3-5x increase in invention volume without proportional hiring. The architecture is built to scale with cloud-native orchestration (e.g., LangGraph) and API integrations to PLM, ALM, and ELM systems.

This agent ingests native CAD files (SolidWorks, Autodesk Inventor), BOMs, and engineering requirements to extract mechanical, electrical, and software features. It uses geometric reasoning and NLP to identify novel assemblies, material compositions, and functional interactions that form the basis for composition-of-matter or apparatus claims. Integration with PLM systems like Siemens Teamcenter ensures the analysis uses the latest revision.

This component cross-references prototype testing data (from QMS like MasterControl or Greenlight Guru) and regulatory submission drafts (e.g., for FDA 510(k)) with the extracted features. It identifies performance claims, safety mechanisms, and unique clinical benefits documented during verification/validation that can strengthen method-of-use or system claims, creating a defensible link between IP and cleared intended use.

A coordinator agent deploys specialized search agents to query patent databases (USPTO, EPO, JPO), medical device registries (FDA's 510(k), EUDAMED), and scientific literature using the normalized feature set. It performs semantic similarity analysis across mechanical and medical vocabularies to assess novelty and flag potential freedom-to-operate risks specific to the device class, routing high-risk findings for immediate legal review.

This integration pipeline automatically structures assessment outputs—novel features, prior art reports, correlated test evidence—into draft disclosure forms and pushes them to Enterprise Legal Management (ELM) systems like Anaqua or CPA Global. It syncs critical dates, inventor data, and filing statuses bi-directionally, eliminating dual entry and ensuring the IP pipeline is a traceable part of the device history record (DHR).

Before any draft filing is generated, the workflow routes findings through configurable approval gates. A patent committee dashboard presents the agent's novelty assessment, proposed claim scope, and prior art heatmap. In-line editing and override controls allow IP counsel and lead engineers to refine the focus, add defensive publications, or kill non-strategic filings, maintaining legal oversight and strategic alignment.

A centralized observability layer tracks the workflow's performance: invention capture rate, average time from prototype freeze to disclosure, and portfolio coverage by device subsystem (e.g., fluidics, sensors, UI). It monitors agent confidence scores, exception rates, and integration health with CAD/PLM/QMS systems, providing ops data to tune the pipeline and report IP ROI to R&D leadership.

Drives implementation to shorten invention-to-filing cycles and prevent IP leakage from fast-moving prototype sprints. Benefits from automated scanning of CAD models, test reports, and engineering requirements to surface patentable features without manual scientist recall. The workflow integrates with PLM/ALM systems (e.g., Siemens Teamcenter, PTC Windchill) to tag IP directly to product components.

Benefits from structured, pre-vetted invention dossiers that reduce prior-art search and drafting labor by 40-60%. Drives requirements for audit trails, claim consistency, and integration with docketing systems (e.g., Anaqua, CPA Global). The workflow automates the generation of draft specifications and figures from technical schematics, allowing legal to focus on high-value strategic refinement and prosecution.

Drives integration with Quality Management Systems (QMS) and regulatory submission pipelines (e.g., eCTD) to ensure IP claims are aligned with design history files and cleared for market submission. Benefits from automated traceability between patent claims, verified product specifications, and testing evidence, which strengthens regulatory filings and reduces amendment risk during FDA/EMA reviews.

Benefits from a data-driven IP gap analysis that maps prototype features against competitor portfolios and technology roadmaps. Drives the business rules for IP prioritization based on commercial potential. The workflow provides strategic briefs on white space and freedom-to-operate (FTO) heatmaps, enabling more informed go/no-go decisions and resource allocation for development pipelines.

Drives the ingestion of validation reports, clinical trial data, and biocompatibility studies into the IP assessment loop. Benefits from automated flagging of novel efficacy data or unique patient outcomes that can support method-of-use claims. The workflow ensures that IP protection extends beyond mechanical design to encompass clinical evidence and unique therapeutic applications.

Drives the technical implementation, ensuring the orchestration layer (e.g., LangGraph, temporal workflows) integrates securely with ERP (SAP), PLM, QMS, and cloud data lakes. Benefits from a scalable, governable architecture that reduces shadow IT and manual data reconciliation. Responsible for exception routing, model observability, and maintaining the audit trail required for legal defensibility.